3: Preventing complications of diabetes
Related Experiment Video
Updated: Aug 30, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Katherine L Bate1, George Jerums
1Endocrinology Unit, Austin Health, Studley Road, Heidelberg, VIC 3084, Australia. kbate@smartchat.net.au
Insights
Effective diabetes management, including controlling blood sugar and blood pressure, significantly reduces the risk of serious complications. Early screening and aggressive treatment of risk factors are crucial for preventing long-term health issues in diabetic patients.
Area of Science:
- Endocrinology
- Cardiology
- Diabetology
Background:
- Diabetes complications significantly increase healthcare costs and patient morbidity.
- Microvascular issues are primary concerns in type 1 diabetes, while macrovascular diseases dominate type 2 diabetes outcomes.
- Hyperglycemia and hypertension are key risk factors for diabetes-related complications.
Purpose of the Study:
- To outline strategies for preventing and managing diabetes complications.
- To emphasize the importance of glycemic and blood pressure control.
- To highlight the role of multifactorial risk factor management.
Main Methods:
- Review of current guidelines and evidence for diabetes complication management.
- Analysis of the impact of glycemic control (HbA1c < 7%) and hypertension management (BP < 130/80 mmHg).
- Assessment of multifactorial interventions including behavior modification and pharmacological therapies for dyslipidemia and cardiovascular risk factors.
Main Results:
- Glycemic and blood pressure control effectively prevent microvascular complications in both type 1 and type 2 diabetes.
- Multifactorial approaches reduce micro- and macrovascular complications in type 2 diabetes.
- Treating dyslipidemia offers significant benefits, comparable to non-diabetic populations.
Conclusions:
- Aggressive management of hyperglycemia and hypertension is essential for preventing diabetes complications.
- Early screening and intervention for risk factors are critical for long-term patient health.
- Pharmacological interventions like ACE inhibitors and aspirin are indicated for diabetic patients with cardiovascular risk factors.
Abstract:
Diabetes complications are common and almost triple the annual cost of managing diabetes. Microvascular complications are the major risk in type 1 diabetes, while macrovascular complications are the major cause of morbidity and mortality in type 2 diabetes. Control of hyperglycaemia (target HbA(1c) level < or = 7%) and hypertension (target blood pressure < or = 130/80 mmHg) prevents microvascular complications in both types of diabetes; a multifactorial approach, comprising behaviour modification and pharmacological therapy for all risk factors, reduces the development of micro- and macrovascular complications in type 2 diabetes. The benefit of treating dyslipidaemia is at least as great in the diabetic population as in the non-diabetic population. Angiotensin-converting enzyme inhibitors and low-dose aspirin are indicated in people with diabetes and other cardiovascular risk factors. Regular annual screening for diabetes complications allows treatable disease to be identified. Aggressive management of hyperglycaemia and other risk factors can prevent many complications
Related Concept Videos
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Retinopathy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...